May 7, 2014
National Cancer Center Hospital East The health ministry’s pilot program for a new access system dubbed a Japanese version of “compassionate use” has begun at a hospital in Chiba Prefecture, with Sanofi K.K.’s prostate cancer agent cabazitaxel becoming the first...read more